Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Lishizhen Modern Biological Medicine Group is a prominent Chinese healthcare enterprise headquartered in Qichun, the hometown of the legendary herbalist Li Shizhen. The company specializes in the modernization of Traditional Chinese Medicine (TCM), focusing on the research, development, and manufacturing of moxibustion products, herbal supplements, and health-oriented consumer goods. Its product portfolio includes high-quality moxa sticks, essential oils, and various TCM-based formulations aimed at wellness and disease prevention. The group operates a large-scale industrial park and integrates cultivation, processing, and distribution to maintain a comprehensive supply chain for TCM products. By combining traditional wisdom with modern biological technology, the company has established itself as a leader in the Chinese herbal medicine and health industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Lishizhen Modern Biological Medicine Group.